Personal Capital Advisors Corp Amgen Inc Transaction History

Personal Capital Advisors Corp

$20.6 Billion
Q4 2022

A detailed history of Personal Capital Advisors Corp transactions in Amgen Inc stock. As of the latest transaction made, Personal Capital Advisors Corp holds 390,429 shares of AMGN stock, worth $123 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

390,429

Previous 389,114 0.34%

Holding current value

$123 Million

Previous $87.7 Million 16.92%

% of portfolio

0.5%

Previous 0.47%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $301,174 - $382,678	1,315 Added 0.34%	390,429 $103 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $1.99 Million - $2.24 Million	8,862 Added 2.33%	389,114 $87.7 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $1.68 Million - $1.87 Million	7,293 Added 1.96%	380,252 $92.5 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $6.37 Million - $7.05 Million	29,054 Added 8.45%	372,959 $90.2 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $6.17 Million - $7.06 Million	31,032 Added 9.92%	343,905 $77.5 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $874,127 - $1.02 Million	4,118 Added 1.33%	312,873 $66.5 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $5.69 Million - $6.31 Million	24,346 Added 8.56%	308,755 $75.3 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $4.64 Million - $5.4 Million	20,889 Added 7.93%	284,409 $70.8 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $2.69 Million - $3.2 Million	12,438 Added 4.95%	263,520 $60.6 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $315,838 - $351,238	1,346 Added 0.54%	251,082 $63.8 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $182,183 - $223,563	921 Added 0.37%	249,736 $58.9 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $1.09 Million - $1.44 Million	5,967 Added 2.46%	248,815 $50.6 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $2.35 Million - $3.02 Million	12,427 Added 5.39%	242,848 $58.5 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $320,188 - $383,652	1,839 Added 0.8%	230,421 $44.6 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $3.28 Million - $3.85 Million	19,696 Added 9.43%	228,582 $42.1 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $2.46 Million - $2.77 Million	13,575 Added 6.95%	208,886 $39.7 Million
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $1.5 Million - $1.75 Million	8,424 Added 4.51%	195,311 $38 Million
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $1.82 Million - $2.05 Million	9,831 Added 5.55%	186,887 $38.7 Million
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $2.85 Million - $3.21 Million	17,185 Added 10.75%	177,056 $32.7 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $4.83 Million - $5.64 Million	28,486 Added 21.68%	159,871 $27.3 Million
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $2.64 Million - $2.95 Million	15,628 Added 13.5%	131,385 $22.8 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $19.4 Million - $22.1 Million	115,757	115,757 $21.6 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.

Account

Personal Capital Advisors Corp Amgen Inc Transaction History